DENVER, July 10, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, today announced it has entered into a definitive agreement for the issuance and sale of an aggregate of 5,242,464 shares of its common stock (or common stock equivalents in lieu thereof) at a purchase price of $0.763 per share of common stock (or per common stock equivalent in lieu thereof), in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, …

U.S. stocks are overbought — but overbought does not mean sell.

EQT Corp (NYSE:EQT) is down 1.5% at $54.06 at last glance, extending a pullback from its June 23, record high of $61.02.

Methode Electronics, Inc. (NYSE:MEI ) Q4 2025 Earnings Conference Call July 10, 2025 11:00 AM ET Company Participants Jonathan B. DeGaynor - President, CEO & Director Laura M.

The ultimate family vacation has completed construction and is one step closer to its August debut in Port Canaveral (Orlando), Florida MIAMI , July 10, 2025 /PRNewswire/ -- Royal Caribbean kicked off the countdown to a new era of family vacations, officially welcoming Star of the Seas * into the family. After nearly two years of construction at the Meyer Turku shipyard in Turku, Finland , the keys to the next revolutionary Icon Class ship were officially handed over to Royal Caribbean just a few weeks ahead of its August debut in Port Canaveral (Orlando), Florida.

Wells Fargo reportedly sees signs of an economic slowdown, with job creation slowing and inflation expected to rise.

Mereo BioPharma Group plc's phase 3 ORBIT study for setrusumab in osteogenesis imperfecta will continue to final analysis, expected by end of 2025. The recent 35% MREO stock drop was due to not meeting early efficacy stopping criteria of ORBIT, not due to safety or trial failure. The ongoing phase 2/3 ORBIT study is targeting OI patients ages 5 to 25, while the phase 3 COSMIC trial is going after patients ages 2 to < 7 years.

WARREN, N.J., July 10, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced the completion and official opening of its fully functional, newly expanded corporate headquarters in Warren, New Jersey. The build-out and first-year operating costs were personally gifted by Founder and Chief Executive Officer Ryan Saadi, M.D., M.P.H., resulting in no expense to the Company or its shareholders.

CNBC's Steve Kovach joins the "Power Lunch" team to discuss Apple CEO Tim Cook's future with the company, Apple's AI struggles and more.

- Multimodal foundation model enables personalized cognitive forecasts and expands access to Alzheimer's diagnostics - POTOMAC, MD / ACCESS Newswire / July 10, 2025 / IGC Pharma, Inc. (NYSE American:IGC) a clinical-stage biopharmaceutical company focused on Alzheimer's disease, today announced the development of MINT-AD, Multimodal Interpretable Transformer for Alzheimer's, the Company's proprietary AI-powered diagnostic platform designed to identify individuals at high risk of cognitive decline years before symptoms appear. MINT-AD leverages diverse data sources including brain scans, genetics, lifestyle, and cognitive metrics, to produce clinically interpretable risk profiles and forecast decline trajectories.

Company's New Jersey Division wins over a dozen awards, including Townhome Community of the Year for Middletown Walk Company's New Jersey Division wins over a dozen awards, including Townhome Community of the Year for Middletown Walk

Shares of Estee Lauder Companies Inc (NYSE:EL, ETR:ELAA) rose 6.5% on Thursday after Bank of America reinstated coverage of the beauty giant with a “Buy” rating and a $110 price objective, implying a 30% upside from current levels. The brokerage cited growing confidence in Estee Lauder's “Beauty Reimagined” turnaround plan, forecasting 4% annual revenue growth through fiscal 2027 and a 430 basis-point improvement in operating margin to 12%.

CNBC's "Power Lunch" team is joined by Thomas Martin, senior portfolio manager at Globalt Investments, to discuss what technology companies he is watching.

The all-time high run is what Larry Tentarelli considers the biggest bullish signal for a higher run following investor resilience through tariffs and the Big, Beautiful Bill. Larry has several stocks on his radar, from Uber Technologies (UBER) as a rideshare leader, to GE Vernova's (GEV) role in powering A.I.

HOUSTON--(BUSINESS WIRE)--Chevron today announced a donation of $250,000 to three community partners, Community Foundation of the Texas Hill Country, Team Rubicon and the Fuel Relief Fund, to support flood relief efforts in Central and West Texas. Community Foundation of the Texas Hill Country will receive $100,000 to support local organizations providing rescue, relief and recovery services. Team Rubicon will receive $100,000 to assess damage, manage volunteers and prepare for large-scale debr.

SAN FRANCISCO--(BUSINESS WIRE)--Marin Software Incorporated (“Marin,” or the “Company”), announced today that it will implement a proposed financial reorganization transaction (the “Transaction”) that is expected to bolster its financial position, better serve its customers around the world and effectively position the Company for long-term success in the AI age. Marin remains fully operational during the reorganization process and expects there will be no impact to its installed customer base.

TORONTO , July 10, 2025 /PRNewswire/ - Franco-Nevada Corporation announced today that it will report its second quarter 2025 results as follows: Second Quarter 2025 Results Release: August 11th before market open Conference Call and Webcast: August 11th 10:00 am ET Dial-in Numbers: Toll-Free: 1-888-510-2154 International: 437-900-0527 Conference Call URL (This allows participants to join the conference call by phone without operator assistance. Participants will receive an automated call back after entering their name and phone number): bit.ly/4eKyqSq Webcast: www.franco-nevada.com Replay (available until August 18th): Toll-Free: 1-888-660-6345 International: 289-819-1450 Passcode: 16615# For more information, please visit our website at www.franco-nevada.com.

Astera Labs' rapid revenue growth and recently-achieved profitability, driven by AI demand, highlight strong execution and industry relevance. Diversification into China and Singapore helped offset decreasing support from Intel. Despite a high valuation, Astera Labs' robust growth, operational efficiency, and expanding market presence justify a buy rating.

Eversource Energy has refocused on its core regulated utility business, divesting non-core assets for greater earnings predictability and stability. The stock offers a 4.66% dividend yield, with a 27-year history of increases, and is expected to outpace inflation through 2030. Valuation models indicate ES is trading at a 26% discount to fair value, supporting a projected 13.5%-16% annual total return over five years.

Kinross Gold remains undervalued despite strong outperformance, offering a compelling entry point with attractive free cash flow and solid asset quality. The company boasts a strong balance sheet, manageable debt, stable production, and could be well-positioned for a potential acquisition. Kinross offers a sustainable yield through dividends and buybacks, supported by robust cash flows and a disciplined capital allocation strategy.